|
Topics
Posts
Gallery
Blog
Comments
Friends
My Content
29 Apr 2009
OK so I had a long chat with Dr Chu yesterday and talked to him about PRP. I showed him this site and all the relevant web pages and I bookmarked them for him.
He agreed PRP with dermaroller is an effective treatment. Now Londoners dont get your hopes up that he will offer it anytime soon because he wont be able to. I also showed him the stem cell thread and he said he will read it. He did say however he doesn’t know how the Chinese clinic would separate fibroblasts from stem cells in the advanced Isolagen process – he didn’t understand how this could be done. Will let you know if I hear anything, but please don’t ask me to contact him on your behalf. I had to take a full day off of work to see him. Going there is no walk in the park for me. Thanks
12 Apr 2009
The last paragraph is the most encouraging. OnlineApril 10, 2009 Sam Lister, Health Editor People left with unsightly scars from injuries or surgery may soon be able to tone down their blemishes with a new drug, research suggests. Tests indicate that the healing drug has the potential to reduce scarring when administered before a surgical operation or on existing scars if the suture is redone. The drug, a synthetic cell-signalling agent called avotermin, is injected under the skin at the site of the wound before and after an incision is made or surgery is carried out on an existing scar. Results from the tests, published in The Lancet, show that it improved the appearance of scars noticeably – as judged by panels of lay volunteers and experts. Related Links Hospitals report surge in weight-loss surgery What can my daughter do about a disfiguring red scar on her chin? Look, no scars: organs removed via the mouth The scientists who led the study said that in some cases the drug reduced redness and "lowered" the scar, making it feel more like normal skin. In others, it improved scars to the point that they could be located only with temporary tattoo markers. Earlier research had identified transforming growth factor beta3 (TGFbeta3), a cytokine signalling molecule that sends messages between cells, as a possible anti-scarring therapy. Three trials were conducted on groups of volunteers who were given centimetre-wide puncture wounds in their arms. The incisions were deep enough to penetrate the skin to underlying muscle. Varying doses of avotermin, an artificial form of TGFbeta3, were injected at the wound site both before and 24 hours after injury. Scarring appearance was assessed using a 100-point scale. The higher the number given, the more noticeable the scar was judged to be. Trial participants ranged widely in age and were split into two groups, one receiving the anti-scarring therapy and the other a dummy treatment. In two trials, lower doses of the drug improved scarring appearance by up to eight points after 12 months. A third trial using higher doses resulted in improvements of as much as 64 points. About a third of the participants experienced a high level of improvement, a third had slight improvement, and in a third of cases there was no change. No side effects were reported. Avotermin affected the orientation, density and thickness of the collagen fibres that cause scarring, the studies showed. Professor Mark Ferguson, from the University of Manchester, said that the treatment suggested that major changes to scarring treatment were possible. He said that with 42 million Europeans and 43 million Americans undergoing surgery every year, it could be of enormous benefit, adding that a trial into revision surgery – when people have an existing scar recut and sewn up – was also under way. “Some people got a really dramatic effect, where the scar was almost imperceptible. We had to tattoo temporary markers to either end of the cut because 12 months later we couldn’t see where the scar was,” he said. “If the drug continues to work and be approved it could be used in surgeries, following trauma and burns, from road traffic accidents to elective surgery and cosmetic procedures.” Professor Ferguson and his colleagues wrote in The Lancet paper that they detected “substantial differences in collagen organisation in some participants, with avotermin-treated scars more closely resembling the basket-weave pattern of normal skin”. The researchers added: “With low doses injected locally around the time of surgery, avotermin is a well tolerated and convenient treatment. These studies suggest that avotermin has potential to provide an accelerated and permanent improvement in scarring.” Brendan Eley, chief executive of the Healing Foundation, said that TGFbeta3 had been one of the "holy grails" of anti-scarring therapy for some time, and described the results as encouraging. “That the impact on scar formation is both structural and aesthetic is very promising. What impact these therapies could have on patients with complicated and potentially disfiguring wounds – that’s the exciting next step of this work which the clinical community will await with eager anticipation," he said.
5 Apr 2009
If anyone is looking for something to do in between treatments and to make their skin look awesome get one of those peels by Dr Chu. For two days I looked scar free because it makes your skin so tight. I think he called it the PABA peel
15 Jan 2009
Will fellow veterans of profractional, CO2 fraxel and dermabrasion tell me what they think of these treatments for skin elasticity?
I am young but had a problem with a filler and had to get two steriod injections so I my skin elasticity is terrible on my left cheek. I now have a waxy look to this side of my face. I am devastated. Can anyone tell me which treatment has worked well for them? Thanks so much, Heidi
30 Dec 2008
Can you combine fillers and lasers? I am wanting to get rid of a filler and was told by a PS to do fractional but wanted to know if anyone has combined the two?
thanks |
Guest Book
Other users have left no comments for heidi55.
Last Visitors
Friends
There are no friends to display.
|
| Time is now: 21st November 2009 09:21 AM |